P. Schoenfeld Asset Management LLP : Form 8.3 - Berendsen

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
78
P. Schoenfeld Asset Management LLP : Form 8.3 - Berendsen plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: P. Schoenfeld Asset Management LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree Berendsen Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken:      For an opening position disclosure, state the latest practicable date prior to the disclosure 28 Jun 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A" Yes, Elis SA  

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   30p ordinary
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled:        
(2) Cash-settled derivatives:   2,170,132 1.26    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:        
       TOTAL: 2,170,132 1.26    

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
         

(b)        Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
30p ordinary Equity Swap   Increasing a long position 50,000 GBP 12.00  

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
           

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
  None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None  

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? No
Date of disclosure: 29 June 2017
Contact name: Alan Chan
Telephone number: +1 212-649-9500

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Goodyear's Strategic Shift: New Leadership, New Path

Updated Category News Views 100

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Continue Reading
Celebrating Science with Southeastern Tile's Sponsorship

Updated Category News Views 65

Crafting Pathways and Fostering Curiosity In this world of rapid change and relentless innovation, supporting education—especially in science and technology—is like buying a piece of the future. And, boy, is Southeastern Tile Connection onto something with that. They've stepped up as an Exploration Sponsor for the Asheville Museum of Science's (AMOS) annual gala,...

Continue Reading
PVA Unveils Hotel Accessibility Guide for Disabled Travelers

Updated Category News Views 169

Is Your Hotel Truly Accessible? Time to Find Out. Another day, another step toward making the world a bit more navigable for folks with mobility challenges—and it's about time the hospitality sector caught up. Today, Paralyzed Veterans of America (PVA) rolled out the first volume of their 'Best Practices in Hotel Accessibility Guide.' Think of it as a roadmap for hotels...

Continue Reading
Guizhou's Mountain Conference Pushes Tourism Evolution

Updated Category News Views 0

Climbing High: Guizhou's Tourism Summit The 2026 International Conference of Mountain Tourism and Outdoor Sports in Guizhou has kicked off with a heartfelt focus on merging natural allure with modern tourism. This isn't just another gathering; it's a powerhouse of international dialogue harbored right in China's dramatic landscape. Building on Unique Natural Assets...

Continue Reading
Lauri Thompson Joins UWSN Board: A New Era Begins

Updated Category News Views 56

Fresh Faces and New Perspectives In a move that merges legal acumen with community heart, Lauri S. Thompson of Greenberg Traurig has stepped up as a board member for the United Way of Southern Nevada (UWSN). Now, why should we care about this? Because when someone with Thompson's clout and eight-arm octopus of involvement links up with a nonprofit, things get interesting....

Continue Reading
SpaceMap Tackles Space Traffic With AI Innovation

Updated Category News Views 150

SpaceMap Takes Aim at the Crowded Space Above You ever look up and wonder what's hurtling above our noggins? More satellites than you can shake a stick at, that's what. And don't even start me on the debris floating around. This ain't just rocket science anymore; it's a crowded dance floor, and someone's gotta manage it. Enter SpaceMap, a plucky South Korean startup that...

Continue Reading
Summit Midstream's Q3 Financial Results Signal Growth

Updated Category News Views 47

Summit Midstream Delivers Strong Q3 Results Good grief, you'd think the grease is sliding off the griddle with these numbers. Summit Midstream Corporation (NYSE:SMC) is putting up figures that ought to make even the most poker-faced of traders crack a smile. We've got a net income sitting pretty at $15.9 million, and an Adjusted EBITDA that's climbed up to $70.7 million....

Continue Reading
Dutch Consumers Open to Recycling, Trust Lags Behind

Updated Category News Views 0

Dutch Consumers: Committed But Skeptical You think positive outlooks on clothing recycling mean business is booming, but scratch beneath the surface, and you'll find over 80% of Dutch consumers keen on recycling—but half of them think their efforts might be going to waste. Reju, a trailblazer in textile regeneration, gathered insights from more than a thousand Dutch...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 69

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading
Edgewise Therapeutics' Investor Play: What's the Buzz?

Updated Category News Views 95

Edgewise Therapeutics Maps Out Investor Terrain Alright, Edgewise Therapeutics, folks. They're shaking things up, and I mean that literally and figuratively. This clinical-stage cardiac biotech isn’t just sitting on its hands; they're out there hustling at the Guggenheim 3rd Annual Healthcare Innovation Conference. Buckle up, because the heart of their...

Continue Reading

Top 5 Most Recently Viewed Articles

Hyundai America Technical Center Fuels Safety Initiatives

Updated Category News Views 173

Here’s the deal: Hyundai America Technical Center, Inc. (HATCI) just plopped down a cool $25,000 into C.S. Mott Children's Hospital’s safety initiatives. That cash is going straight into free resources like car seats and helmets—vital stuff for the community, especially when it comes to keeping kids safe on the streets. What’s the angle here? HATCI isn’t just...

Continue Reading
The Future of Precious Metals Amid USD Strength: Insights

Updated Category News Views 255

Understanding the Current Landscape of Precious Metals In recent times, the precious metals market, particularly gold and silver, has been witnessing significant fluctuations. Analysts have observed that while gold futures have experienced a notable increase, this may not align with broader market signals. Gold Futures and Market Dynamics The gold futures market recently...

Continue Reading
Man Group PLC's Strategic Position in Financial Markets

Updated Category News Views 205

Man Group PLC's Strategic Disclosure Overview In the dynamic world of finance, transparency and accountability play crucial roles in maintaining investor confidence. Man Group PLC, a prominent player on the London Stock Exchange, is dedicated to adhering to these principles. This article delves into the recent public opening position disclosures made by Man Group PLC,...

Continue Reading
Bio-Path Initiates Obesity Program with BP1001-A Candidate

Updated Category News Views 86

Bio-Path's New Venture into Obesity Treatment Bio-Path Holdings, Inc. has taken a significant leap forward by initiating a new therapeutic program focused on obesity and related metabolic diseases. This groundbreaking program revolves around the development of BP1001-A, leveraging their proprietary DNAbilize technology. This marks an exciting shift in direction, as it is...

Continue Reading
Active Pharmaceutical Ingredients Market Growth and Trends to Watch

Updated Category News Views 175

Transforming the Pharmaceutical Landscape through APIs The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is revolutionizing how drugs are developed and produced globally. Active Pharmaceutical Ingredients (APIs) have transitioned from being mere components in drug production to essential assets that...

Continue Reading